Identifiers
Database identifiers and provenance.
- Ligand ID
APR- PDB
1rrm- UniProt (similar protein)
P0A9S1- Target protein
- PA1146
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- MW ≤ 500 Da 559.3
- LogP ≤ 5 -3.28
- H-bond donors ≤ 5 8
- H-bond acceptors ≤ 10 17
- Rotatable bonds ≤ 10 9
- TPSA ≤ 140 Ų 291.5
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
c1nc(c2c(n1)n(cn2)[C@H]3[C@@H]([C@@H]([C@H](O3)CO[P@](=O)(O)O[P@](=O)(O)OC[C@@H]4[C@H]([C@H]([C@@H](O4)O)O)O)O)O)Nc1nc(c2c(n1)n(cn2)[C@H]3[C@@H]([C@@H]([C@H](O3)CO[P@](=O)(O)O[P@](=O)(O)OC[C@@H]4[C@H]([C@H]([C@@H](O4)O)O)O)O)O)N
InChI=1S/C15H23N5O14P2/c16-12-7-13(18-3-17-12)20(4-19-7)14-10(23)8(21)5(32-14)1-30-35(26,27)34-36(28,29)31-2-6-9(22)11(24)15(25)33-6/h3-6,8-11,14-15,21-25H,1-2H2,(H,26,27)(H,28,29)(H2,16,17,18)/t5-,6-,8-,9-,10-,11-,14-,15-/m1/s1InChI=1S/C15H23N5O14P2/c16-12-7-13(18-3-17-12)20(4-19-7)14-10(23)8(21)5(32-14)1-30-35(26,27)34-36(28,29)31-2-6-9(22)11(24)15(25)33-6/h3-6,8-11,14-15,21-25H,1-2H2,(H,26,27)(H,28,29)(H2,16,17,18)/t5-,6-,8-,9-,10-,11-,14-,15-/m1/s1
SRNWOUGRCWSEMX-KEOHHSTQSA-NSRNWOUGRCWSEMX-KEOHHSTQSA-N
Provenance
Annotation context from LigQ_2 search.
- Method
- LigQ nearest_k
- Source
- PDB
- Binding sites
- PF00465
External resources
Open this ligand in third-party databases and cheminformatics tools.
- PDB RCSB ligand APR →
- PDB RCSB structure 1rrm →
- UniProt UniProt P0A9S1 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “APR”) →
Other binders for this protein
Quick navigation to other ligands bound to PA1146.
PDB 4
Ligands co-crystallized with this protein (structural evidence).
ZINC 50
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).